AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 41 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $23,000 | -95.2% | 37,000 | -77.5% | 0.00% | -90.0% |
| Q1 2018 | $476,000 | -36.4% | 164,300 | -38.7% | 0.03% | -25.0% |
| Q4 2017 | $748,000 | -48.0% | 268,200 | -31.9% | 0.04% | -48.1% |
| Q3 2017 | $1,438,000 | +2719.6% | 394,000 | +311.3% | 0.08% | +1825.0% |
| Q4 2016 | $51,000 | -75.4% | 95,800 | -58.8% | 0.00% | -76.5% |
| Q3 2016 | $207,000 | -26.3% | 232,657 | -20.5% | 0.02% | -34.6% |
| Q2 2016 | $281,000 | +75.6% | 292,800 | +129.5% | 0.03% | +30.0% |
| Q4 2015 | $160,000 | -24.2% | 127,600 | +5.1% | 0.02% | -31.0% |
| Q2 2015 | $211,000 | -56.1% | 121,400 | -63.7% | 0.03% | -56.7% |
| Q1 2015 | $481,000 | +208.3% | 334,100 | +78.3% | 0.07% | +157.7% |
| Q4 2014 | $156,000 | +11.4% | 187,400 | +49.9% | 0.03% | +23.8% |
| Q3 2014 | $140,000 | +94.4% | 125,000 | +213.3% | 0.02% | +90.9% |
| Q2 2014 | $72,000 | +67.4% | 39,900 | +66.9% | 0.01% | +57.1% |
| Q4 2013 | $43,000 | – | 23,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 20,896,038 | $17,135,000 | 0.89% |
| X-Square Capital, LLC | 270,680 | $222,000 | 0.15% |
| New Leaf Venture Partners, L.L.C. | 402,118 | $330,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 688,431 | $565,000 | 0.06% |
| EXCALIBUR MANAGEMENT CORP | 51,000 | $42,000 | 0.04% |
| WealthTrust Axiom LLC | 138,505 | $113,000 | 0.04% |
| Caption Management, LLC | 855,200 | $701,000 | 0.04% |
| Evercore Wealth Management, LLC | 418,414 | $343,000 | 0.01% |
| Gemmer Asset Management LLC | 1,939 | $32,000 | 0.01% |
| Ausdal Financial Partners, Inc. | 23,000 | $19,000 | 0.01% |